1
|
Chen J, Song Y, Zhou M, Yang M, Zhang L, Naeem A, Li Z, Deng Y, Liu Y, Ai Z, Su D. Screening for potential quality markers of Callerya nitida var. hirsutissima. Z.Wei based on components profile, pharmacokinetics, and anti-inflammatory study. J Sep Sci 2021; 45:638-649. [PMID: 34729921 DOI: 10.1002/jssc.202100543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Revised: 10/25/2021] [Accepted: 10/26/2021] [Indexed: 11/07/2022]
Abstract
Callerya nitida var. hirsutissima. Z.Wei is a classical, traditional Chinese herbal medicine mostly used to treat rheumatoid arthritis. Recent reports suggest that inconsistent and poor-quality control levels have primarily affected the therapeutic efficacy. Therefore, the aim of the current study was to investigate the active chemical ingredients, stability of components in blood, pharmacokinetics, and pharmacodynamics to specify the potential markers for quality control and quality evaluation of Callerya nitida. The active components in vitro and in vivo were obtained by ultra-high-performance liquid chromatography-mass spectrometry. Moreover, the changes of the bioactive components in the blood were monitored over time (0-24 h) in order to identify stable active components. On this basis, the pharmacokinetic characteristics of these ingredients combined with the anti-inflammatory activity were determined to screen out the potential markers for ensuring the quality control of Callerya nitida. The identified four components, such as calycosin, daidzein, formononetin, and 5-hydroxymethylfurfural, have the characteristics of intrinsic components, clearly defined structures, high exposure values, and in vivo stability, which are important for the therapeutic activity of pharmacologically active materials. Therefore, they can be used as potential markers to control the quality levels of Callerya nitida.
Collapse
Affiliation(s)
- Jingbin Chen
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Yonggui Song
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Mingyue Zhou
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Ming Yang
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China.,Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, State Key Lab of Innovation Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Ling Zhang
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Abid Naeem
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Zexie Li
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Yaqiong Deng
- Nanchang Medical College, Nanchang University, Nanchang, P. R. China
| | - Yali Liu
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China.,Nanchang Medical College, Nanchang University, Nanchang, P. R. China
| | - Zhifu Ai
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| | - Dan Su
- Key Laboratory of Depression Animal Model based on TCM Syndrome, Jiangxi Administration of Traditional Chinese Medicine, Key Laboratory of TCM for Prevention and Treatment of Brain Diseases with Cognitive Impairment Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, P. R. China
| |
Collapse
|
2
|
Tan J, Liu J, Wang H, Zhang Y, Lin H, Wang Z, Si H, Zhang Y, Liu J, Li P, Sun K. Identification of blood-activating components from Xueshuan Xinmaining Tablet based on the spectrum-effect relationship and network pharmacology analysis. RSC Adv 2020; 10:9587-9600. [PMID: 35497256 PMCID: PMC9050128 DOI: 10.1039/c9ra09623j] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Accepted: 02/18/2020] [Indexed: 01/03/2023] Open
Abstract
With the aim of identifying the active components of Xueshuan Xinmaining Tablet (XXT) and discussing the potential mechanism involved, the relationship between HPLC fingerprints and its blood-activating effect were established by multivariate statistical analysis, including gray relational analysis (GRA) and partial least squares regression analysis (PLSR). Network pharmacology was used to predict the potential mechanism based on the identified active components. GRA and PLSR analysis showed close correlation between the HPLC fingerprints and blood-activating activity, and peaks P1, P3, P11, P15, P22, P34, P36, P38 and P39 might be potential anti-blood stasis components of XXT. The pharmacological verification showed that salvianic acid A (P1), rutin (P3), ginsenoside Rg1 (P11) and Rb1 (P22), cinobufagin (P36), and tanshinone I (P38) and IIA (P39) had significant blood-activating effects. Based on these seven active compounds, network pharmacology analysis indicated that the anti-blood stasis effect of XXT might be closely related to TNF, PI3K-Akt and NF-κB signaling pathways. The spectrum-effect relationship of XXT was successfully established in this study. The blood-activating components and the anti-blood stasis mechanism were revealed and predicted. These findings could also be beneficial for an exploration of the active components of TCM.
Collapse
Affiliation(s)
- Jing Tan
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| | - Junli Liu
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| | - Han Wang
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| | - Ying Zhang
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
- The First Hospital of Jilin University Changchun 130021 Jilin China
| | - Hongqiang Lin
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| | - Zhongyao Wang
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| | - Hanrui Si
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| | - Yutong Zhang
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| | - Jinping Liu
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
- Research Center of Natural Drug, Jilin University Changchun 130021 China
| | - Pingya Li
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
- Research Center of Natural Drug, Jilin University Changchun 130021 China
| | - Kai Sun
- School of Pharmaceutical Sciences, Jilin University Fujin Road 1266 Changchun 130021 Jilin China +86-431-85619803
| |
Collapse
|
3
|
Xiao RY, Wu LJ, Hong XX, Tao L, Luo P, Shen XC. Screening of analgesic and anti-inflammatory active component in Fructus Alpiniae zerumbet
based on spectrum-effect relationship and GC-MS. Biomed Chromatogr 2017; 32. [DOI: 10.1002/bmc.4112] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2017] [Revised: 09/29/2017] [Accepted: 09/29/2017] [Indexed: 11/10/2022]
Affiliation(s)
- Rui-Yao Xiao
- The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- Department of Pharmacognosy, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- The GMC-Guiyang City United Laboratory for Natural Medicinal Pharmacology and Drugability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi Univeristy Town; Guian New District 550025 Guizhou China
| | - Ling-Jing Wu
- The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- The GMC-Guiyang City United Laboratory for Natural Medicinal Pharmacology and Drugability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi Univeristy Town; Guian New District 550025 Guizhou China
| | - Xiao-Xiao Hong
- The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- The GMC-Guiyang City United Laboratory for Natural Medicinal Pharmacology and Drugability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi Univeristy Town; Guian New District 550025 Guizhou China
| | - Ling Tao
- The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- The GMC-Guiyang City United Laboratory for Natural Medicinal Pharmacology and Drugability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi Univeristy Town; Guian New District 550025 Guizhou China
| | - Peng Luo
- The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- The GMC-Guiyang City United Laboratory for Natural Medicinal Pharmacology and Drugability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi Univeristy Town; Guian New District 550025 Guizhou China
| | - Xiang-Chun Shen
- The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- Department of Pharmacology of Chinese Material Medica, School of Pharmaceutical Science; Guizhou Medical University, Huaxi University Town; Guian New District 550025 Guizhou China
- The GMC-Guiyang City United Laboratory for Natural Medicinal Pharmacology and Drugability, School of Pharmaceutical Science; Guizhou Medical University, Huaxi Univeristy Town; Guian New District 550025 Guizhou China
| |
Collapse
|
4
|
Yang W, Zhang Y, Wu W, Huang L, Guo D, Liu C. Approaches to establish Q-markers for the quality standards of traditional Chinese medicines. Acta Pharm Sin B 2017; 7:439-446. [PMID: 28752028 PMCID: PMC5518652 DOI: 10.1016/j.apsb.2017.04.012] [Citation(s) in RCA: 101] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2017] [Revised: 04/19/2017] [Accepted: 04/20/2017] [Indexed: 10/25/2022] Open
Abstract
Traditional Chinese medicine (TCM) has played a pivotal role in maintaining the health of Chinese people and is now gaining increasing acceptance around the global scope. However, TCM is confronting more and more concerns with respect to its quality. The intrinsic "multicomponent and multitarget" feature of TCM necessitates the establishment of a unique quality and bioactivity evaluation system, which is different from that of the Western medicine. However, TCM is investigated essentially as "herbal medicine" or "natural product", and the pharmacopoeia quality monographs are actually chemical-markers-based, which can ensure the consistency only in the assigned chemical markers, but, to some extent, have deviated from the basic TCM theory. A concept of "quality marker" (Q-marker), following the "property-effect-component" theory, is proposed. The establishment of Q-marker integrates multidisciplinary technologies like natural products chemistry, analytical chemistry, bionics, chemometrics, pharmacology, systems biology, and pharmacodynamics, etc. Q-marker-based fingerprint and multicomponent determination conduce to the construction of more scientific quality control system of TCM. This review delineates the background, definition, and properties of Q-marker, and the associated technologies applied for its establishment. Strategies and approaches for establishing Q-marker-based TCM quality control system are presented and highlighted with a few TCM examples.
Collapse
|
6
|
Zhang JM, Fu CM, Hu YC, Li Y, Qing SH, Gao F. Screening out Potential Cardio-Toxic Components of Chinese HerbRadix Aconiti Lateralisin Rat Dosed Plasma by High Performance Liquid Chromatography/Electrospray Ionization Quadrupole Time-Of-Flight Mass Spectrometry. ANAL LETT 2012. [DOI: 10.1080/00032719.2012.677791] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|